231 related articles for article (PubMed ID: 9620378)
1. Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.
Kirk SM; Schell RF; Moore AV; Callister SM; Mazurek GH
J Clin Microbiol; 1998 Jun; 36(6):1568-73. PubMed ID: 9620378
[TBL] [Abstract][Full Text] [Related]
2. E-test: an alternative method for susceptibility testing of Mycobacterium tuberculosis.
Akcali S; Cicek C; Surucuoglu S; Ozbakkaloglu B
Med Princ Pract; 2005; 14(4):264-7. PubMed ID: 15961938
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
Bergmann JS; Woods GL
J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
DeCoster DJ; Vena RM; Callister SM; Schell RF
Clin Microbiol Infect; 2005 May; 11(5):372-8. PubMed ID: 15819863
[TBL] [Abstract][Full Text] [Related]
5. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
Wanger A; Mills K
J Clin Microbiol; 1996 Jul; 34(7):1672-6. PubMed ID: 8784567
[TBL] [Abstract][Full Text] [Related]
6. Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.
Norden MA; Kurzynski TA; Bownds SE; Callister SM; Schell RF
J Clin Microbiol; 1995 May; 33(5):1231-7. PubMed ID: 7615733
[TBL] [Abstract][Full Text] [Related]
7. Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry.
Moore AV; Kirk SM; Callister SM; Mazurek GH; Schell RF
J Clin Microbiol; 1999 Mar; 37(3):479-83. PubMed ID: 9986799
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Joloba ML; Bajaksouzian S; Jacobs MR
J Clin Microbiol; 2000 Oct; 38(10):3834-6. PubMed ID: 11015413
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.
Bergmann JS; Fish G; Woods GL
Arch Pathol Lab Med; 2000 Jan; 124(1):82-6. PubMed ID: 10629136
[TBL] [Abstract][Full Text] [Related]
10. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
[TBL] [Abstract][Full Text] [Related]
11. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid.
Reis RS; Neves I; Lourenço SL; Fonseca LS; Lourenço MC
J Clin Microbiol; 2004 May; 42(5):2247-8. PubMed ID: 15131202
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Commercial Kit SIRE Nitratase for detecting resistant Mycobacterium tuberculosis in Brazil.
Miranda SS; Almeida IN; Lopes ML; Figueiredo JDR; Figueredo LJA; Kritski AL; Carvalho WDS; Mansur MFFO
Rev Soc Bras Med Trop; 2017; 50(4):550-553. PubMed ID: 28954080
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the E-test and proportion methods for susceptibility testing of Mycobacterium tuberculosis.
Sanic A; Gunaydin M; Coban AY; Tokac ; Cetin M
J Chemother; 2000 Dec; 12(6):491-4. PubMed ID: 11154031
[TBL] [Abstract][Full Text] [Related]
14. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis.
Yajko DM; Madej JJ; Lancaster MV; Sanders CA; Cawthon VL; Gee B; Babst A; Hadley WK
J Clin Microbiol; 1995 Sep; 33(9):2324-7. PubMed ID: 7494021
[TBL] [Abstract][Full Text] [Related]
15. A novel agar base medium for drug susceptibility testing of
Coban AY
Future Microbiol; 2021 Sep; 16():949-953. PubMed ID: 34384261
[No Abstract] [Full Text] [Related]
16. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN
J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B
J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022
[TBL] [Abstract][Full Text] [Related]
19. Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.
Coban AY
PLoS One; 2013; 8(2):e55370. PubMed ID: 23405140
[TBL] [Abstract][Full Text] [Related]
20. Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry.
Fredricks BA; DeCoster DJ; Kim Y; Sparks N; Callister SM; Schell RF
J Microbiol Methods; 2006 Nov; 67(2):266-72. PubMed ID: 16704883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
